- Beneficial effect of MET-88, a gamma-butyrobetaine hydroxylase inhibitor, on energy metabolism in ischemic dog hearts. Kirimoto, T., Nobori, K., Asaka, N., Muranaka, Y., Tajima, K., Miyake, H. Archives internationales de pharmacodynamie et de thérapie. (1996)